🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

The Effect Of Partner-Assısted Rebozo Technıque On Labor Paın And Satısfactıon In Prımary Pregnant Women

RecruitingNAAges 18 Years - 49 YearsFemaleIstanbul Saglik Bilimleri University
NCT07752693 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The main objective of this study is to examine the effect of the rebozo technique, applied with partner support, on labor pain and birth satisfaction in primiparous pregnant women. This research is planned as a randomized controlled experimental study. A total of 64 pregnant women, 32 in the control group and 32 in the experimental group, who meet the sample selection criteria and agree to participate in the study, will constitute the sample of the study. Participants included in the study will be administered the Informed Consent Form, the "Demographic Information Form" created by the researcher, the "Fathers' Participation in Birth Scale", VAS scoring, "Birth Care Guide", "Observation Form Regarding Labor" and the "Birth Satisfaction Scale". Data will be analyzed using appropriate statistical methods. It is expected that the results obtained will contribute to the use of non-pharmacolo

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Those aged between 18 and 49, * Between 37-42 weeks of gestation, * Primiparous pregnancy, * In head presentation, the fetus is singular, * Those who have not been diagnosed with a high-risk pregnancy, * Someone who understands and can speak Turkish, * In the active phase (5cm and above), * The spouse is allowed to be present at the birth. Exclusion Criteria: * Those who experienced adjustment problems in the study, * Patients who require an emergency cesarean section, * Pregnancy with a known high-risk diagnosis (IUGR, fetal anomaly, polyhydramnios or oligohydramnios, presentation anomaly, multiple pregnancy, preeclampsia, etc.)
💊

What it tests

  • Rebozo Technique
📍

Where

1 site
Çerkezköy State Hospital
Tekirdağ, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy